Abstract
Background
Interest in non-hormonal therapies for the treatment of menopausal symptoms has increased since the publication of adverse effects of estrogen replacement therapy.
Objective
To provide information on the efficacy of non-hormonal therapies for menopausal vasomotor symptoms based on evidence from published randomised controlled studies.
Methods
The Cochrane Database of Systematic Reviews (CDSR), MEDLINE, Alternative Therapies in Health and Medicine database (ATHMD) and Allied and Complementary Medicine database (AMED) were searched for randomised controlled trials in the English language reporting data on treatment of menopausal vasomotor symptoms. Trials including cancer breast patients were included.
Results
Our search identified 58 randomised controlled trials of which 11 involved the use of clonidine, six for SSRIs, four for gabapentin, seven for black cohosh, seven for red clover, 18 for phytoestrogens, two for ginseng, one for evening primrose, one for dong quai and one for vitamin E. Most trials had methodological deficiencies.
Conclusion
There is evidence that clonidine, paroxetine, venlafaxine, gabapentin and black cohosh may be beneficial in the treatment of menopausal vasomotor symptoms in some women. Current evidence does not support the use of fluoxetine, red clover, phytoestrogens, Ginseng, evening primrose, dong quai and vitamin E. The side effects profile of these therapies should be considered.
Similar content being viewed by others
References
http://www.statistics.gov.uk/populationestimates. Cited 30 Mar 2007)
Bachmann GA (1999) Vasomotor flushes in menopausal women. Am J Obstet Gynecol 180:S312–S316
Rossouw JE, Anderson GL, Prentice RL,LaCroix AZ, Kooperberg C, Stefanil ML et al (2002) Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women’s Health Initiative randomized clinical trial. JAMA 288:321–333
Beral V (2003) Million Women Study Collaborators Breast cancer and hormone replacement therapy in the Million Women Study. Lancet 362: 419–427
Hersh AL, Stefanik ML, Stafford RS (2004) National use of postmenopausal hormone therapy. JAMA 291:47–53
Lawton B, Rose, McLeod D, Dowell A (2003) Changes in use of hormone replacement therapy after the report from Women’s Health Initiative: cross sectional survey of users. BMJ 327:845–846
Nelson HD, Vesco KK, Haney E, Fu R, Nedrow A, Miller J, Nicolaides C, Walker M, Humphrey L (2006) Nonhormonal therapies for menopausal hot flashes: systematic review and meta-analysis. JAMA 295:2057–2071
Goldberg RM, Loprinzi CL, O’Fallon JR et al (1994) Transdermal clonidine for ameliorating tamoxifen-induced hot flashes. Clin Oncol 12:155–158
Pandya KJ, Raubertas RF, Flynn PJ et al (2002) Oral clonidine in postmenopausal patients with breast cancer experiencing tamoxifen induced hot flashes: a University of Rochester Cancer Center Community Clinical Oncology Program study. Ann Intern Med 132:788–793
Edington RF, Chagnon (1980) Clonidine (Dixarit) for menopausal flushing. Can Med Assoc J 123:23–26
Nagamani M, Kelver ME, Smith ER (1987) Treatment of menopausal hot flashes with transdermal administration of clonidine. Am J Obstet Gynecol 156:561–565
Clayden JR, Bell JW, Pollard P (1974) Menopausal flushing: double-blind trial of a non-hormonal medication. BMJ 1(5905):409–412
Bolli P, Simpson FO (1975) Clonidine in menopausal flushing: a double blind trial. A N Z Med J 82:1196–1197
Lindsay R, Hart DM (1978) Failure of response of menopausal vasomotor symptoms to clonidine. Maturitas 1:21–25
Salmi T, Punnonen R (1979) Clonidine in treatment of menopausal symptoms. Int J Gynaecol Obstet 16:422–426
Wren BG, Brown LB (1986) A double-blind trial with clonidine and a placebo to treat hot flushes. Med J Aust 144:369–370
Nappi C, Petraglia F, de Chiara BM et al (1991) The effect of various drugs with neuroendocrine activity and transdermal estradiol on plasma gonadotropin concentrations after ovariectomy in reproductive-aged women. Acta Obstet Gynecol Scand 70:435–439
Sadovsky R (2000) Clonidine reduces tamoxifen-induced hot flushes. Am Fam Physician 62(9):2115
Stearns V, Beebe KL, Iyengar M, Dube E (2003) Paroxetine controlled release in the treatment of menopausal hot flashes: a randomized controlled trial. JAMA 289:2827–2834
Stearns V, Slack R, Greep N et al (2005) Paroxetine is an effective treatment for hot flashes: results from a prospective randomized clinical trial. J Clin Oncol 23:6919–6930
Evans ML, Pritts E, Vittinghoff E, McClish K, Morgan KS, Jaffe RB (2005) Management of postmenopausal hot flashes with venlafaxine hydrochloride: a randomized, controlled trial. Obstet Gynecol 105:61–66
Loprinzi C, Kugler J, Sloan J, Mailliard J, LaVasseur B, Barton D, Novotny P, Dakhil S, Rodger K, Rummans T (2000) Venlafaxine in management of hot flashes in survivors of breast cancer: a randomised controlled trial. Lancet 356(9247):2059–2063
Loprinzi CL, Sloan JA, Perez EA, Quella SK, Stella PJ, Mailliard JA et al (2002) Phase III evaluation of fluoxetine for treatment of hot flashes. J Clin Oncol 20:1578–1583
Suvanto-Luukkonen E, Koivunen R, Sundstrom H (2005) Citalopram and fluoxetine in the treatment of postmenopausal symptoms: a prospective, randomized, 9-month, placebo-controlled, double-blind study. Menopuase 12(1):18–26
Guttuso TJ, Kurlan R, McDermott MP, Kieburtz K (2003) Gabapentin’s effect on hot flashes in postmenopausal women: a randomized controlled trial. Obstet Gynecol 101:337–345
Pandaya KJ, Morrow GR, Roscoe JA, Zhao H, Hickok JT, Pajon E, Sweeney TJ, Banerjee TK, Flynn PJ (2005) Gabapentin for hot flashes in 420 women with breast cancer: a randomized double-blind placebo-controlled trial. Lancet 366(9488):818–824
Reddy SY, Warner H, Guttuso T, Messing S, DiGrazio W, Thornburg L, Guzick DS (2006) Gabapentin, estrogen and placebo for treating hot flushes: a randomized controlled trial. Obstet Gynecol 108:41–48
Loprinzi CL, Kugler JW, Barton DL, Dueck AC, Tschetter LK, Nelimark RA et al (2007) Phase III trial of gabapentin alone or in conjunction with an antidepressant in the management of hot flashes in women who have inadequate control with an antidepressant alone: NCCTG N03C5. Clin Oncol 25:308–312
Uebelhack R, Blohmer JU, Graubaum HJ, Busch R, Gruenwald J, Wernecke KD (2006) Black cohosh and St. John’s wort for climacteric complaints: a randomized trial. Obstet Gynecol 107:247–255
Osmers R, Friede M, Liske E (2005) Efficacy and safety of isopropanolic black cohosh extract for climacteric symptoms. Obstet Gynecol 105:1074–1078
Wuttke W, Seidlove-Wuttke, Gorkow (2003) The Cimicifuga preparation BNO 1055 vs. conjugated estrogens in a double-blind placebo-controlled study: effects on menopause symptoms and bone markers. Maturitas 14(44 Suppl 1):67–77
Pockaj BA, Gallagher JG, Loprinzi CL, Stella PJ, Barton DL (2006) Phase III double-blind, randomized, placebo-controlled crossover trial of black cohosh in the management of hot flashes. J Clin Oncol 24(18):2836–2841
Newton KM, Reed SD, Grothaus L, Ehrlich K, Guiltinan J, Ludman E, Lacroix AZ (2001) Randomized trial of black cohosh for the treatment of hot flashes among women with a history of breast cancer. J Clin Oncol 19(10):2739–2745
Verhoeven MO, Van der Mooren MJ, Van de Weijer PH (2005) Effect of a combination of isoflavones and Actaea racemosa Linnaeus on climacteric symptoms in healthy symptomatic perimenopausal women: a 12-week randomized, placebo-controlled, double-blind study. Menopause 12(4):412–420
Frei-Kleiner S, Schaffner W, Rahlfs VW (2005) Cimicifuga racemosa dried ethanolic extract in menopausal disorders: a double-blind placebo-controlled clinical trial. Maturitas 51(4):397–404
Van de Weijer, Barentsen R (2002) Isoflavones from red clover (Promensil) significantly reduce menopausal hot flush symptoms compared with placebo. Maturitas 42(3):187–189
Hidalgo L, Chedraui P, Morocho N, Ross S (2005) The effect of red clover isoflavones on menopausal symptoms, lipids and vaginal cytology in menopausal women: a randomized, double-blind, placebo-controlled study. Gynecol Endocrinol 21(5):257–264
Jeri AR (2002) The use of an isoflavone supplement to relieve hot flashes. Female patient 27:35–37
Atkinson C, Warren R, Sala E , Dowsett M, Dunning A (2004) Red clover-derived isoflavones and mammographic breast density: a double-blind, randomized, placebo-controlled trial [ISRCTN42940165]. Breast Cancer Res 6:170–179
Tice JA, Ettinger B, Ensrud K, Wallace R, Blackwell T, Cummings SR (2003) Phytoestrogen supplements for the treatment of hot flashes: the Isoflavone Clover Extract (ICE) study: a randomized controlled trial. JAMA 290:207–214
Knight DC, Howes JB, Eden JA (1999) The effect of Promensil, an isoflavone extract, on menopausal symptoms. Climacteric 2:79–84
Baber RJ, Templeman C, Morton T, Kelly GE, West L (1999) Randomized placebo-controlled trial of an isoflavone supplement and menopausal symptoms in women. Climacteric 2:85–92
Krebs EE, Ensrud KE, MacDonald R, Wilt TJ (2004) Phytoestrogens for treatment of menopausal symptoms: a systematic review. Obstet Gynecol 104(4):824–836
MacGregor CA, Canney PA, Patterson G, McDonald R, Paul J (2005) A randomised double-blind controlled trial of oral soy supplements versus placebo for treatment of menopausal symptoms in patients with early breast cancer. Eur J Cancer 41(5):708–714
Van Patten CL, Olivotto IA, Chambers GK, Gelmon KA, Hislop TG, Templeton E et al (2002) Effect of soy phytoestrogens on hot flashes in postmenopausal women with breast cancer: a randomized, controlled clinical trial. J Clin Oncol 20:1449–1455
Quella SK, Loprinzi CL, Barton DL, Knost JA, Sloan JA, LaVasseur BI et al (2000) Evaluation of soy phytoestrogens for the treatment of hot flashes in breast cancer survivors: a North Central Cancer Center Treatment Group Trial. J Clin Oncol 18:1068–1074
Secreto G, Chiechi LM, Amadori A, Miceli R, Venturelli E, Valerio T et al (2004) Soy isoflavones and melatonin for the relief of climacteric symptoms: a multicenter, double-blind, randomized study. Maturitas 47:11–20
Lewis JE, Nickell LA, Thompson LU, Szalai JP, Kiss A, Hilditch JR (2006) A randomized controlled trial of the effect of dietary soy and flaxseed muffins on quality of life and hot flashes during menopause. Menopause 13(4):631–642
Nikander E, Kilkkinen A, Metsä-Heikkilä M, Adlercreutz H, Pietinen P, Tiitinen A, Ylikorkala O (2003) A randomized placebo-controlled crossover trial with phytoestrogens in treatment of menopause in breast cancer patients. Obstet Gynecol 101(6):1213–1220
Penotti M, Fabio E, Modena AB, Rinaldi M, Omodei U, Vigano P (2003) Effect of soy-derived isoflavones on hot flushes, endometrial thickness, and the pulsatility index of the uterine and cerebral arteries. Fertil Steril 79:1112–1117
Duffy R, Wiseman H, File SE (2003) Improved cognitive function in postmenopausal women after 12 weeks of consumption of a soy extract containing isoflavones. Pharmacol Biochem Behav 75:721–729
St Germain A, Peterson CT, Robinson JG, Alekel DL (2001) Isoflavone-rich or isoflavone-poor soy protein does not reduce menopausal symptoms during 24 weeks of treatment. Menopause 8:17–26
Kotsopoulos D, Dalais FS, Liang YL, McGrath BP, Teede H (2000) The effects of soy protein containing phytoestrogens on menopausal symptoms in postmenopausal women. Climacteric 3:161–167
Baber RJ, Templeman C, Morton T, Kelly GE, West L (1999) Randomized placebo-controlled trial of an isoflavone supplement and menopausal symptoms in women. Climacteric 2:85–92
Crisafulli A, Marini H, Bitto A et al (2004) Effects of genistein on hot flushes in early postmenopausal women: a randomized, double-blind EPT- and placebo-controlled study. Menopause 11:400–404
Han KK, Soares JM Jr, Haidar MA, de Lima GR, Baracat EC (2002) Benefits of soy isoflavone therapeutic regimen on menopausal symptoms. Obstet Gynecol 99:389–394
Faure E, Chantre P, Mares P (2002) Effects of a standardized soy extract on hot flushes: a multicenter, double-blind, randomized, placebo-controlled study. Menopause 9:329–334
Upmalis DH, Lobo R, Bradley L, Warren M, Cone FL, Lamia CA (2000) Vasomotor symptom relief by soy isoflavone extract tablets in postmenopausal women: a multicenter, double-blind, randomized, placebo-controlled study. Menopause 7:236–242
Washburn S, Burke GL, Morgan T, Anthony M (1999) Effect of soy protein supplementation on serum lipoproteins, blood pressure, and menopausal symptoms in perimenopausal women. Menopause 6:7–13
Murkies AL, Lombard C, Stauss BJ, Wilcox G, Burger HG, Morton MS (1995) Dietary flour supplementation decreases postmenopausal hot flushes: effect of soy and wheat. Maturitas 21:189–195
Wiklund IK, Mattsson LA, Lindgren R, Limoni C (1999) Effects of standardized ginseng extract on quality of life and physiological parameters in symptomatic postmenopausal women: a double-blind, placebo-controlled trial. Int J Clin Pharmacol Res 19:89–99
Hartley DE, Elsabagh S, File SE (2004) Gincosan (a combination of Ginkgo biloba and Panax ginseng): the effects on mood and cognition of 6 and 12 weeks’ treatment in post-menopausal women. Nutr Neurosci 7(5–6):325–333
Chenoy R, Hussain S, Tayob Y, O’Brien PM, Moss MY, Morse PF (1994) Effect of oral gamolenic acid from evening primrose oil on menopausal flushing. BMJ 308:501–503
Hirata JD, Swiersz LM, Zell B, Small R, Ettinger B (1997) Does dong quai have estrogenic effects in postmenopausal women? A double-blind, placebo-controlled trial. Fertil Steril 68:981–986
Barton DL, Loprinzi CL, Quella SK, Sloan JA, Veeder MH, Egner JR et al (1998) Prospective evaluation of vitamin E for hot flashes in breast cancer survivors. J Clin Oncol 16:495–500
Guttuso TJ (2000) Gabapentin’s effect on hot flashes and hypothermia. Neurology 54:2161–2163
FugateS, Church C (2004) Nonestrogen treatment modalities for vasomotor symptoms associated with menopause. Ann Pharmacother 38:1482–1499
Mahady GB, Gyllenhall C, Fong HH, Farnsworth NR (2000) Ginsengs: a review of safety and efficacy. Nutr Clin Care 3:90–101
World Health Organization. WHO monographs on selected medicinal plants. Geneva: World Health Organization, 1999
Nelson HD (2004) Commonly used types of postmenopausal estrogen for treatment of hot flashes: scientific review. JAMA 291:1610–1620
Lobo RA, Belisle S, Creasman WT, Frankel NR, Goodman NF, Hall JE et al (2006) Should symptomatic menopausal women be offered hormone therapy? MedGenMed 8(3):40
Newton KM, Reed SD, LaCroix AZ, Grothaus LC, Ehrlich K, Guiltinan J (2006) Treatment of vasomotor symptoms of menopause with black cohosh, multibotanicals, soy, hormone therapy, or placebo: a randomized trial. Ann Intern Med 145(12):869–879
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Cheema, D., Coomarasamy, A. & El-Toukhy, T. Non-hormonal therapy of post-menopausal vasomotor symptoms: a structured evidence-based review. Arch Gynecol Obstet 276, 463–469 (2007). https://doi.org/10.1007/s00404-007-0390-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00404-007-0390-9